CrowdStrike’s Annual Threat Hunting Report Reveals One Potential Intrusion Is Identified Every Seven Minutes
Findings from Falcon Overwatch threat hunters showed faster breakout times by eCrime adversaries and one…
News
James Kim Joins Ares Management as Head of European Special Opportunities in the Ares Private Equity Group
Mr. Kim Brings Significant Global Private Equity and Leveraged Finance Experience to Support Ares’ Continued…
One Biosciences Initiates LARYCARE Clinical Study, Its Second Discovery Program
The LARYCARE study aims at discovering new predictive biomarkers to treatment response and at developing…
TechTarget Archer Awards Recognize APAC’s Best in Data-Driven Marketing and Sales
Seven regional winners are all leveraging intent data to drive breakthrough digital results NEWTON, Mass.–(BUSINESS…
Benitec Biopharma Inc. Announces Pricing of $18 Million Underwritten Public Offering
HAYWARD, Calif., Sept. 12, 2022 (GLOBE NEWSWIRE) — Benitec Biopharma Inc. (Nasdaq: BNTC) (“Benitec” or…
HERE SDK Navigate now available in Japan
HERE SDK Navigate now available in Japan HERE SDK Navigate now available in Japan …
LBank Exchange Will List AssetMantle (MNTL) on September 13, 2022
Internet City, Dubai–(Newsfile Corp. – September 12, 2022) – LBank Exchange, a global digital asset…
Crestwood Announces Pricing of Secondary Offering of Common Units and Concurrent Common Unit Repurchase
HOUSTON–(BUSINESS WIRE)–Crestwood Equity Partners LP (NYSE: CEQP) (“Crestwood”) today announced the pricing of the previously…
Advaxis Reports Third Quarter Ended July 31, 2022 Financial Results and Provides a Business Update
Announced completion of first dose level and enrollment initiation for second dose level in investigator-sponsored…
Celsion Corporation Presentation Time at the H.C. Wainwright 24th Annual Global Investment Conference Changed to 4:30 p.m. ET on September 13
LAWRENCEVILLE, N.J., Sept. 12, 2022 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: CLSN), a clinical-stage drug development…
CANbridge Pharmaceuticals to Participate in Two Investor Conferences in September
BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals, Inc. (HKEX:1228) , a China and U.S.-based global biopharmaceutical…
Entera Bio to Present at H.C. Wainwright 24th Annual Global Investment Conference
JERUSALEM, Sept. 12, 2022 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the…
Rubius Therapeutics to Provide Strategic Update
Investor Teleconference and Webcast Scheduled Tomorrow, September 13, 2022, at 7:30 a.m. EDT CAMBRIDGE, Mass.,…
Baseball Legend John Smoltz Featured on PLx Pharma’s Social Channels
Legendary Baseball Pitcher and Avid Golfer Uses VAZALORE® 325 mg for Fast, Effective Pain Relief…
22nd Century Group (Nasdaq: XXII) Appoints Accomplished Media Executive Lucille S. Salhany to Its Board
Pioneer Entertainment Executive to Extend Digital Media Expertise to Company’s Mission in Tobacco Harm Reduction…
Apellis Pharmaceuticals Announces New Presentation Time at the Bank of America Global Healthcare Conference
WALTHAM, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical…
Adamis Provides an Enrollment Update on the Phase 2/3 Study of Tempol in COVID-19 Positive High-Risk Subjects
The clinical trial of Tempol has reached the initial planned enrollment of 248 subjects Independent…
ERYTECH Provides Business and Financial Update for the First Half of 2022
ERYTECH Provides Business and Financial Update for the First Half of 2022 Conference call and…
Codiak Announces Proposed Public Offering of Common Stock and Warrants
CAMBRIDGE, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) — Codiak BioSciences, Inc. (Nasdaq: CDAK) (“Codiak”), a…
Aquestive Therapeutics Announces Expert Allergy Scientific Advisory Board
WARREN, N.J., Sept. 12, 2022 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical…